SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-108770
Filing Date
2017-04-03
Accepted
2017-04-03 17:28:34
Documents
6
Period of Report
2017-03-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d365134d8k.htm 8-K 18264
2 EX-1.1 d365134dex11.htm EX-1.1 162047
3 EX-5.1 d365134dex51.htm EX-5.1 8648
4 EX-99.1 d365134dex991.htm EX-99.1 8276
5 EX-99.2 d365134dex992.htm EX-99.2 8689
6 GRAPHIC g365134g0403085529960.jpg GRAPHIC 2260
  Complete submission text file 0001193125-17-108770.txt   210424
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 17735400
SIC: 2834 Pharmaceutical Preparations